Autoimmune myopathy (Q41407): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A miopatia autoimune é um subgrupo de miopatias inflamatórias idiopáticas que, apesar de terem diversas causas, apresentam as características histopatológicas comuns de necrose de miócitos sem inflamação significativa. Os pacientes apresentam uma miopatia proximal simétrica grave subaguda, associada a um nível de creatinoquinase acentuadamente elevado. Eles são mais provavelmente imunomediados, pois respondem à imunoterapia. É frequentemente acompanhada por terapia com estatinas, doenças do tecido conjuntivo, câncer e autoanticorpos específicos para partícula de reconhecimento de sinal (SRP) ou 3-hidroxi-3-metilglutaril-coenzima A redutase (HMGCR). | |||||||||||||||
| description / en | description / en | ||||||||||||||
Autoimmune myopathy is a subgroup of idiopathic inflammatory myopathies, which, despite diverse causes, have the common histopathological features of myocyte necrosis without significant inflammation. Patients present with a subacute severe symmetrical proximal myopathy, associated with a markedly elevated creatine kinase level. These are most likely immune-mediated, as they respond to immunotherapy. It is often accompanied by statin therapy, connective tissue diseases, cancer, and autoantibodies specific for signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl–coenzyme A reductase (HMGCR). | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1227790808 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:8C81 | |||||||||||||||
| Property / CURIE: CID11:8C81 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-8C81 | |||||||||||||||
| Property / Canary Token: dki-india-8C81 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: G72 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:34, 13 August 2026
Autoimmune myopathy is a subgroup of idiopathic inflammatory myopathies, which, despite diverse causes, have the common histopathological features of myocyte necrosis without significant inflammation. Patients present with a subacute severe symmetrical proximal myopathy, associated with a markedly elevated creatine kinase level. These are most likely immune-mediated, as they respond to immunotherapy. It is often accompanied by statin therapy, connective tissue diseases, cancer, and autoantibodies specific for signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl–coenzyme A reductase (HMGCR).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 8C81 |
||
| English | Autoimmune myopathy |
Autoimmune myopathy is a subgroup of idiopathic inflammatory myopathies, which, despite diverse causes, have the common histopathological features of myocyte necrosis without significant inflammation. Patients present with a subacute severe symmetrical proximal myopathy, associated with a markedly elevated creatine kinase level. These are most likely immune-mediated, as they respond to immunotherapy. It is often accompanied by statin therapy, connective tissue diseases, cancer, and autoantibodies specific for signal recognition particle (SRP) or 3-hydroxy-3-methylglutaryl–coenzyme A reductase (HMGCR). |
Statements
CID11:8C81
0 references
dki-india-8C81
0 references
Concluído
0 references
13 August 2026
0 references
